Mycosis fungoides and Sezary syndrome: New pathogenetic aspects [Aktuelle aspekte zur pathogenese von Sézary-syndrom und mycosis fungoides]

被引:0
|
作者
Dummer R. [1 ]
Willers J. [1 ]
Döbbeling U. [1 ]
Burg G. [1 ]
机构
[1] Universitätsspital Zürich, Dermatologische Klinik, Zürich
来源
Der Hautarzt | 2001年 / 52卷 / 3期
关键词
Cutaneous T-cell lymphoma; Cytokines; Interferon; Interleukin-15; Mycosis fungoides; Sézary syndrome;
D O I
10.1007/s001050051288
中图分类号
学科分类号
摘要
Cutaneous T-cell lymphomas are a heterogeneous group of lymphoproliferative skin disorders whose pathogenesis is poorly understood. Cytokines and chemokines are important factors which can modify the cutaneous microenvironment allowing the accumulation of lymphocytes. Most of these neoplasms seem to be T helper-2 cells. While interferon gamma is the natural inhibitor of clonal T-cell proliferations, interferon resistance has been recently found in these cells. This interferon resistance may be an Achilles heel that can be targeted by molecular therapeutic interventions.
引用
收藏
页码:189 / 192
页数:3
相关论文
共 50 条
  • [1] Mycosis fungoides and Sezary syndrome:: new pathogenetic aspects
    Dummer, R
    Willers, J
    Döbbeling, U
    Burg, G
    HAUTARZT, 2001, 52 (03): : 189 - 192
  • [2] Lebensqualität von Patienten mit Mycosis fungoides und Sézary-SyndromQuality of Life of Patients With Mycosis Fungoides and Sézary Syndrome
    Manuel Jäger
    Deniz Özistanbullu
    Claus-Detlev Klemke
    Sabine Tratzmiller
    hautnah, 2023, 22 (3) : 156 - 160
  • [3] Multidisciplinary Management of Mycosis Fungoides/Sézary Syndrome
    Sara Berg
    Jennifer Villasenor-Park
    Paul Haun
    Ellen J. Kim
    Current Hematologic Malignancy Reports, 2017, 12 : 234 - 243
  • [4] New aspects of the clinicopathological features and treatment of mycosis fungoides and Sezary syndrome
    Furue, Masutaka
    Kadono, Takafumi
    JOURNAL OF DERMATOLOGY, 2015, 42 (10): : 941 - 944
  • [5] New systemic treatment options in mycosis fungoides and Sézary syndrome
    Magdalena Seidl-Philipp
    Van Anh Nguyen
    memo - Magazine of European Medical Oncology, 2020, 13 : 280 - 284
  • [6] New trends in the management of mycosis fungoides and Sezary syndrome
    Batycka-Baran, Aleksandra
    Reich, Adam
    Jankowska-Konsur, Alina
    Maj, Joanna
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2009, 26 (01): : 41 - 55
  • [7] A new molecular paradigm in mycosis fungoides and Sezary syndrome
    Elenitoba-Johnson, Kojo S. J.
    Wilcox, Ryan
    SEMINARS IN DIAGNOSTIC PATHOLOGY, 2017, 34 (01) : 15 - 21
  • [8] New systemic treatment options in mycosis fungoides and Sezary syndrome
    Seidl-Philipp, Magdalena
    Nguyen, Van Anh
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (03) : 280 - 284
  • [9] Mycosis Fungoides and Sézary Syndrome: Updates and Review of Current Therapy
    Hiroaki Kamijo
    Tomomitsu Miyagaki
    Current Treatment Options in Oncology, 2021, 22
  • [10] New Options in Diagnosis and Management of Mycosis Fungoides and Sezary Syndrome
    Enke, Charles A.
    ONCOLOGY-NEW YORK, 2010, 24 (06): : 507 - 508